• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket

    1/27/23 6:26:54 AM ET
    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Medicinal Chemicals and Botanical Products
    Health Care
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $AKAN alert in real time by email

    Gainers

    • Freightos Limited (NASDAQ:CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I Acquisition Corp.
    • Akanda Corp. (NASDAQ:AKAN) rose 49.2% to $0.4180 in pre-market trading after jumping 47% on Thursday.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) shares rose 19.2% to $0.8950 in pre-market trading after dropping 32% on Thursday. GeoVax recently received a notice of allowance for its zika vaccine patent.
    • BuzzFeed, Inc. (NASDAQ:BZFD) rose 18.7% to $2.48 in pre-market trading. The company’s shares jumped 120% on Thursday following a report suggesting Meta Platforms pays the company millions to generate creator content.
    • Avaya Holdings Corp. (NASDAQ:AVYA) rose 12.8% to $0.3970 in pre-market trading after declining 3% on Thursday.
    • comScore, Inc. (NASDAQ:SCOR) rose 9.9% to $1.33 in pre-market trading.
    • Freight Technologies, Inc. (NASDAQ:FRGT) rose 9.5% to $0.3634 in pre-market trading after jumping 15% on Thursday.
    • Evolve Transition Infrastructure LP (NYSE:SNMP) rose 8.8% to $0.2339 in pre-market trading.
    • Ocugen, Inc. (NASDAQ:OCGN) shares rose 8.3% to $1.30 in pre-market trading. Ocugen recently announced results from the Phase 2/3 study of its COVID-19 vaccine candidate, COVAXIN.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) rose 7.5% to $0.2581 in pre-market trading after jumping 14% on Thursday.

    Losers

    • ContraFect Corporation (NASDAQ:CFRX) fell 21.1% to $0.0727 in pre-market trading after dropping 8% on Thursday.
    • Denali Capital Acquisition Corp. (NASDAQ:DECA) shares fell 12.9% to $9.05 in pre-market trading. Longevity Biomedical and Denali Capital Acquisition Corp. announced a business combination.
    • Genelux Corporation (NASDAQ:GNLX) fell 11.4% to $5.45 in pre-market trading. Genelux announced pricing of $15 million initial public offering of 2.5 million shares of common stock at a price of $6 per share.
    • Biotricity, Inc. (NASDAQ:BTCY) shares dropped 10.5% to $0.79 in pre-market trading after jumping 18% on Thursday. Biotricity signed a distribution agreement with top 5 distributor for its cardiac monitoring solutions.
    • Intel Corporation (NASDAQ:INTC) fell 9.9% to $27.11 in pre-market trading after the company reported weaker-than-expected results for its fourth quarter and issued soft guidance.
    • COMSovereign Holding Corp. (NASDAQ:COMS) fell 9.5% to $0.1041 in pre-market trading after jumping over 58% on Thursday.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 8.3% to $0.2775 in pre-market trading after gaining 6% on Thursday.
    • GeneDx Holdings Corp. (NASDAQ:WGS) shares fell 7.9% to $0.3510 in pre-market trading after the company reported proposed underwritten public offering of class A common stock and concurrent registered direct offering.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) fell 7.8% to $1.78 in pre-market after gaining 14% on Thursday. Sonoma Pharmaceuticals recently announced that Microcyn Rx products have received a Distribution and Price Agreement for distribution by the Defense Logistics Agency.
    • F-star Therapeutics, Inc. (NASDAQ:FSTX) fell 7.2% to $4.02 in pre-market trading after dropping 26% on Thursday.

    Now Read This: American Express, Intel And 3 Stocks To Watch Heading Into Friday

    Get the next $AKAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKAN
    $AVYA
    $BTCY
    $BZFD

    CompanyDatePrice TargetRatingAnalyst
    Ocugen Inc.
    $OCGN
    3/17/2026$12.00Buy
    Canaccord Genuity
    Ocugen Inc.
    $OCGN
    3/11/2026$10.00Outperform
    Oppenheimer
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    GeneDx Holdings Corp.
    $WGS
    2/9/2026$155.00Equal Weight → Overweight
    Wells Fargo
    Intel Corporation
    $INTC
    1/20/2026$50.00Reduce → Hold
    HSBC Securities
    Intel Corporation
    $INTC
    1/20/2026$65.00Neutral → Buy
    Seaport Research Partners
    Intel Corporation
    $INTC
    1/15/2026$50.00Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Meister Keith A. bought $13,460,090 worth of shares (169,521 units at $79.40) (SEC Form 4)

    4 - GeneDx Holdings Corp. (0001818331) (Issuer)

    3/5/26 7:19:34 PM ET
    $WGS
    Retail: Computer Software & Peripheral Equipment
    Technology

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Freudenthaler Paul D

    3 - Freight Technologies, Inc. (0001687542) (Issuer)

    3/19/26 6:43:56 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Gonzalez Leon Jose Andres

    3 - Freight Technologies, Inc. (0001687542) (Issuer)

    3/19/26 6:40:35 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Selgas Javier

    3 - Freight Technologies, Inc. (0001687542) (Issuer)

    3/19/26 6:38:04 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Ocugen with a new price target

    Canaccord Genuity initiated coverage of Ocugen with a rating of Buy and set a new price target of $12.00

    3/17/26 8:33:47 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Oppenheimer initiated coverage on Ocugen with a new price target

    Oppenheimer initiated coverage of Ocugen with a rating of Outperform and set a new price target of $10.00

    3/11/26 8:39:19 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    SEC Filings

    View All

    SEC Form 424B5 filed by Genelux Corporation

    424B5 - GENELUX Corp (0001231457) (Filer)

    3/19/26 5:30:03 PM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Freight Technologies Inc.

    6-K - Freight Technologies, Inc. (0001687542) (Filer)

    3/19/26 5:28:08 PM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    SEC Form S-8 filed by Genelux Corporation

    S-8 - GENELUX Corp (0001231457) (Filer)

    3/19/26 5:27:03 PM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Freight Technologies Releases Pro Forma Financial Statements for JAK Solar Acquisition

    HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (NASDAQ:FRGT, "Fr8Tech" or the "Company")), a logistics management innovation company offering a diverse portfolio of technology-driven solutions, today released the unaudited pro forma financial statements related to its acquisition of JAK Solar Loans 1 Limited ("JAK Solar"), which was completed on December 31, 2025. The unaudited pro forma condensed combined financial information includes a balance sheet as of September 30, 2025 and statements of operations for the nine months ended September 30, 2025 and the year ended December 31, 2024. The pro forma financial statements have been prepared in accordance with Articl

    3/19/26 5:50:45 PM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

    -- Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 -- -- Interim systemic lung cancer data with Olvi-Vec demonstrated partial responses in relapsed small cell lung cancer (SCLC) and early signs of anti-tumor activity in non-small cell lung cancer (NSCLC); additional updates expected throughout 2026 -- -- Appointed Jason Litten, M.D., as Chief Medical Officer to lead clinical development strategy -- -- $33.1 million in pro forma cash, cash equivalents, marketable securities and restricted cash as of December 31, 2025, including $18.5 million in net proceeds from underwritten offering of common stock in January 2026; expected to su

    3/19/26 4:15:00 PM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Comscore Reports Fourth Quarter and Full Year 2025 Results

    RESTON, Va., March 17, 2026 (GLOBE NEWSWIRE) -- Comscore, Inc. (NASDAQ:SCOR), a trusted partner for planning, transacting and evaluating media across platforms, today reported financial results for the fourth quarter and full year ended December 31, 2025. "Our full-year 2025 results reflect solid progress in key strategic areas of our business. We delivered strong double-digit growth in our local TV and cross-platform business lines, both of which helped drive revenue growth year over year," said Jon Carpenter, CEO. "We are pleased with the progress the team has made, and with the recapitalization transaction behind us, we can now focus on unlocking value through strategic transformation

    3/17/26 4:05:00 PM ET
    $SCOR
    Real Estate

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Leadership Updates

    Live Leadership Updates

    View All

    Ethiopian Cargo to Join Freightos' Booking Platform

    eBooking, Interlining and Digital Payments Soon Available Across Africa's Largest Air Cargo NetworkBARCELONA, Spain, March 11, 2026 /PRNewswire/ -- Freightos (NASDAQ:CRGO), the leading booking and payment platform for the international freight industry, today announced that Ethiopian Cargo will join Freightos' cargo booking platform at the end of the month. The integration includes digital rates, quoting and eBooking, WebCargo Pay for fast digital payments, and interlining capabilities platform. Ethiopian Cargo operates Africa's largest air cargo network, serving more than 145 destinations worldwide through a combination of dedicated freighters and passenger belly capacity, and offering frei

    3/11/26 7:00:00 AM ET
    $CRGO
    Integrated Freight & Logistics
    Industrials

    Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer

    MALVERN, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the appointment of Rita Johnson-Greene as Chief Financial Officer (CFO). "Mrs. Johnson-Greene's diverse background across a variety of strategic roles at organizations representing many facets of the industry make her well-suited to serve as Ocugen's CFO," said Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen. "We look forward to her leadership as we enter into a transformative time at Ocugen, beginning with the submission of the first of three Biologics License Applications (BLAs) this

    2/9/26 7:02:00 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

    Recognized neonatologist and payer-strategy leader joins GeneDx to expand earlier diagnosis and establish genomics as a standard of care across healthcare GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights today announced Linda Genen, MD, MPH as Chief Medical Officer to further strengthen the company's commitment to delivering earlier answers and better outcomes for families through genomic insights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106493899/en/GeneDx Names Dr. Linda Genen, MD, MPH as Chief Medical Officer In her role at GeneDx, Dr. Genen will oversee Medical and Cli

    1/6/26 8:30:00 AM ET
    $WGS
    Retail: Computer Software & Peripheral Equipment
    Technology

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Denali Capital Acquisition Corp.

    SC 13G/A - Denali Capital Acquisition Corp. (0001913577) (Subject)

    12/6/24 4:17:05 PM ET
    $DECA
    Blank Checks
    Finance

    Amendment: SEC Form SC 13D/A filed by GeneDx Holdings Corp.

    SC 13D/A - GeneDx Holdings Corp. (0001818331) (Subject)

    11/20/24 9:36:13 PM ET
    $WGS
    Retail: Computer Software & Peripheral Equipment
    Technology

    Amendment: SEC Form SC 13D/A filed by GeneDx Holdings Corp.

    SC 13D/A - GeneDx Holdings Corp. (0001818331) (Subject)

    11/19/24 8:00:24 PM ET
    $WGS
    Retail: Computer Software & Peripheral Equipment
    Technology

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Financials

    Live finance-specific insights

    View All

    Comscore Reports Fourth Quarter and Full Year 2025 Results

    RESTON, Va., March 17, 2026 (GLOBE NEWSWIRE) -- Comscore, Inc. (NASDAQ:SCOR), a trusted partner for planning, transacting and evaluating media across platforms, today reported financial results for the fourth quarter and full year ended December 31, 2025. "Our full-year 2025 results reflect solid progress in key strategic areas of our business. We delivered strong double-digit growth in our local TV and cross-platform business lines, both of which helped drive revenue growth year over year," said Jon Carpenter, CEO. "We are pleased with the progress the team has made, and with the recapitalization transaction behind us, we can now focus on unlocking value through strategic transformation

    3/17/26 4:05:00 PM ET
    $SCOR
    Real Estate

    BuzzFeed, Inc. Reports Q4 and Full Year 2025 Results

    BuzzFeed, Inc.'s ("BuzzFeed" or the "Company") (NASDAQ:BZFD) fourth quarter and full year (ended December 31, 2025) financial results were in line with its outlook shared in November. In 2025, BuzzFeed grew programmatic advertising by 7% year over year, expanded its studio business with three feature films, and advanced product innovation in key areas. "We believe there is a gap between the value of our individual assets and our market capitalization that suggests significant unrecognized upside," said Jonah Peretti, BuzzFeed Founder & CEO. "In 2026, our focus is demonstrating the value of our brands, Studio IP, and new AI apps to the market, and we're actively exploring strategic options

    3/12/26 4:15:00 PM ET
    $BZFD
    Telecommunications Equipment
    Consumer Discretionary

    Comscore to Announce Fourth Quarter and Full Year 2025 Financial Results

    RESTON, Va., March 03, 2026 (GLOBE NEWSWIRE) -- Comscore, Inc. (NASDAQ:SCOR), a trusted partner for planning, transacting and evaluating media, today announced that it plans to hold a conference call to discuss its financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 17th at 5:00 p.m. ET. Interested parties may access the conference call via live webcast at https://edge.media-server.com/mmc/p/8p6drcvp, or participate via telephone by registering in advance at https://register-conf.media-server.com/register/BIfe0c7b40387b48b38269741c4cce4207. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN n

    3/3/26 8:00:00 AM ET
    $SCOR
    Real Estate

    $AKAN
    $AVYA
    $BTCY
    $BZFD
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Air Transport Services Group Inc on Jun 7 Indicate?

    Recently, on June 7, 2024, Michael L Berger, a significant figure at Air Transport Services Group Inc, made a notable insider purchase. Berger bought $49,830 worth of shares, acquiring 3,996 units at a price of $12.47 per share. This transaction increased his direct ownership by 4% to 103,705 units as reported in the SEC Form 4 here. Examining other insider actions within the company can sometimes reveal intriguing patterns that might offer insights for investors. Looking back at previous transactions, we see a series of insider activities at Air Transport Services Group Inc: In March 2024, Dominick Jeffrey A. filed an SEC Form 4, indicating a notable transaction date in which actions were

    6/10/24 12:35:45 AM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care